B. Angrist et al., Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidol, CLIN NEUROP, 24(3), 2001, pp. 139-144
In a series of earlier studies, an oral dose of 0.5 mg/kg d-amphetamine was
administered to 81 patients with schizophrenia and eight normal control su
bjects. Seven more subjects with schizophrenia received placebo. Blood pres
sure and pulse rate were monitored before and 3 hours after drug administra
tion. Blood pressure increased in both amphetamine groups, whereas placebo
had no effect. However, pulse rate did not change in the schizophrenic grou
p and only increased after 3 hours in normal control subjects as blood pres
sure began to decrease. Significant negative correlations between systolic
blood pressure and pulse rate occurred at 2 and 3 hours, suggesting that th
e early cardiovascular response to amphetamine is an increase in blood pres
sure that recruits reflex control of heart rate. Eighteen of these subjects
had hypertensive responses. Six subjects received 5 mg haloperidol intramu
scularly, and 12 others had their blood pressure monitored until normalizat
ion. Haloperidol led to a more rapid decline of some but not all indices of
blood pressure, suggesting that amphetamine-induced hypertension may have
a dopaminergic component.